KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Depreciation & Amortization (CF) (2016 - 2025)

Ionis Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 13 years, most recently at $3.3 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $3.3 million for Q4 2025, up 45.49% from a year ago — trailing twelve months through Dec 2025 was $10.0 million (up 4.1% YoY), and the annual figure for FY2025 was $10.0 million, up 4.1%.
  • Depreciation & Amortization (CF) for Q4 2025 was $3.3 million at Ionis Pharmaceuticals, up from $2.3 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for IONS hit a ceiling of $4.0 million in Q2 2021 and a floor of $2.2 million in Q1 2025.
  • Median Depreciation & Amortization (CF) over the past 5 years was $2.6 million (2023), compared with a mean of $3.0 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): plummeted 33.9% in 2023 and later skyrocketed 45.49% in 2025.
  • Ionis Pharmaceuticals' Depreciation & Amortization (CF) stood at $3.8 million in 2021, then dropped by 20.8% to $3.0 million in 2022, then fell by 15.96% to $2.5 million in 2023, then decreased by 11.95% to $2.2 million in 2024, then skyrocketed by 45.49% to $3.3 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $3.3 million (Q4 2025), $2.3 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.